All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials Open new browser tab
(2022)
Start website main content
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)